Daily FNArena News - Small Caps

Having brought a canine cancer treatment to market, Qbiotic’s focus has returned to treating two-legged cancers including melanoma and other difficult-to-treat cancers

Despite a weaker production result in its third quarter, Coronado Resources has benefitted from strong price realisation

Tim Boreham notes small caps with cash on the balance sheet are the safer bet compared to ‘pre-revenue’ companies, and highlights several examples

A solid first quarter has not been enough for analysts to find upside value in Pilbara Minerals

Imricor is a player in a global catheter ablation market worth $US5.5 billion and growing at a compound rate of just over 8% a year

Baby Bunting has implemented plans to address a -230 basis point gross profit decline year-to-date and analysts expect some recovery can be made

Tyro Payment targets cost savings in a renewed focus on earnings under new management

The acquisition of Smart and Biggar opens up a pathway to replicating the consolidation success IPL Ltd has experienced in Australia in the Canadian market

Brokers ratchet target prices higher on a positive outlook for Karoon Energy

New broker research reinforces the global opportunity for Life360 to become a dominant brand